Profile
Ms. Mira Leiwant is a Senior VP-Quality, Regulatory & Clinical Affairs at Anika Therapeutics, Inc. Ms. Leiwant was previously employed as a Vice President-Regulatory Affairs by BTG International, Inc. and a Senior Director-Regulatory & Quality Engineering by LifeCell Corp.
She received her undergraduate degree from Cornell University and a graduate degree from Cornell University.
Mira Leiwant active positions
| Companies | Position | Start |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-10-13 |
Former positions of Mira Leiwant
| Companies | Position | End |
|---|---|---|
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | General Counsel | - |
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Corporate Officer/Principal | - |
Training of Mira Leiwant
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Health Technology |
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Finance |
- Stock Market
- Insiders
- Mira Leiwant
















